Diuretic Effect: benzthiazide primarily acts as a diuretic by inhibiting sodium and chloride ions reabsorption in the renal tubules of the kidneys. This leads to increased excretion of sodium, chloride, and water in the urine.
Volume Reduction: By promoting the elimination of sodium and water, benzthiazide helps reduce blood volume and, consequently, lowers blood pressure. This makes it a useful medication for managing hypertension (high blood pressure).
Potassium Excretion: While benzthiazide increases the excretion of sodium and water, it also leads to the loss of potassium in the urine. This can potentially lead to hypokalemia (low blood potassium levels), so monitoring of potassium levels is important during treatment.
Spectrum of benzthiazide:
benzthiazide’s effects are primarily related to its diuretic action and its ability to lower blood pressure. It is used to manage several conditions, including:
Hypertension: benzthiazide is often prescribed as an antihypertensive medication to help lower blood pressure. By reducing blood volume, it helps decrease the strain on the heart and blood vessels.
Edema: Due to its diuretic properties, benzthiazide can be used to manage edema (fluid retention) associated with conditions such as heart failure, kidney disorders, and certain liver diseases.
Nephrolithiasis Prevention: benzthiazide may be used to help prevent kidney stones formation by reducing the concentration of calcium in the urine.
Adjunctive Treatment: benzthiazide can be prescribed in combination with other antihypertensive medications to enhance blood pressure control and reduce the dosage of individual drugs.
Calcium Excretion: In addition to sodium and water, benzthiazide also promotes the excretion of calcium in the urine. This effect may be beneficial in certain cases of hypercalcemia.
starting dose: 25-100 mg orally given two times a day after the meals
Maintenance dose: 50-150 mg daily given orally in 2-3 divided doses. Maximum recommended dose is 200 mg daily orally in 2-4 divided doses
Dose Adjustments
Dosing modifications Renal impairment
CrCl less than 25 mL/min: usually not recommended.
CrCl 25 to 80 mL/min: starting dose: 25 mg orally given two times a day after the meals. Maintenance dose: 50-100 mg daily given orally in a single or in two divided doses. Liver impairment
Not known
Safety & efficacy were not established
Refer to the adult dosing regimen
Frequency not defined
Hyperuricemia
hypokalemia
Hyponatremia
hypophosphatemia
hyperglycemia
hyperuricemia
Metabolic alkalosis
Hypomagnesemia
Hypercalcemia
hypercholesterolemia
Orthostatic hypotension
Diarrhea
Nausea
vomiting
Dizziness
Paresthesia
Xanthopsia
Restlessness
headache
Black Box Warning:
There is no known black box warning specifically associated with benzthiazide.
Contraindication/Caution:
Contraindication:
Hypersensitivity: Individuals with a known hypersensitivity or allergy to benzthiazide or other thiazide diuretics should not use this medication.
Severe Renal Impairment: benzthiazide is primarily eliminated through the kidneys. Individuals with severe renal impairment or kidney failure may not be able to effectively eliminate the drug, leading to potential accumulation and adverse effects. The medication may be contraindicated in this population.
Anuria: Anuria refers to the absence of urine production. benzthiazide’s mechanism of action relies on the production of urine to eliminate excess fluid and electrolytes. In cases of anuria, the medication’s effectiveness may be limited, and its use is contraindicated.
Hepatic Encephalopathy: benzthiazide can alter fluid and electrolyte balance in the body, which could potentially worsen hepatic encephalopathy, a neurological condition that occurs in advanced liver disease. Therefore, its use may be contraindicated in individuals with this condition.
Hypokalemia: Severe hypokalemia (low blood potassium levels) may be exacerbated by benzthiazide, as it promotes potassium excretion in the urine. Use in individuals with severe hypokalemia could lead to further imbalances and is contraindicated.
Electrolyte Imbalance: Individuals with significant electrolyte imbalances, such as hyponatremia (low blood sodium levels) or hypomagnesemia (low blood magnesium levels), should use benzthiazide with caution, as the medication can affect electrolyte levels.
Caution:
Electrolyte Imbalances: benzthiazide’s diuretic effect can lead to electrolyte imbalances, including hypokalemia (low blood potassium levels), hyponatremia (low blood sodium levels), and hypomagnesemia (low blood magnesium levels). Healthcare providers should regularly monitor electrolyte levels and make necessary adjustments to prevent and manage imbalances.
Renal Impairment: benzthiazide is primarily eliminated through the kidneys. Individuals with mild to moderate renal impairment may require dose adjustments or closer monitoring, while those with severe impairment may be at risk of accumulation and should use the medication with caution.
Hepatic Impairment: benzthiazide’s effects on fluid and electrolyte balance can impact individuals with liver disease, potentially worsening hepatic encephalopathy or other complications. Close monitoring and cautious use are advised in this population.
Gout: benzthiazide can elevate uric acid levels in the blood, potentially triggering or exacerbating gout attacks. Individuals with a history of gout should be monitored closely and managed accordingly.
Lipid and Glucose Levels: benzthiazide’s use may impact lipid profiles and glucose tolerance. Monitoring lipid and glucose levels can help manage any potential adverse effects.
Calcium Metabolism: benzthiazide can affect calcium metabolism, leading to potential hypercalcemia (high blood calcium levels). Close monitoring is important in individuals with conditions that can be affected by calcium levels, such as hyperparathyroidism.
Pregnancy and Lactation: The use of benzthiazide during pregnancy and breastfeeding requires careful consideration, as its effects the developing fetus or nursing infant are not well-established.
Comorbidities:
Hypertension: benzthiazide is commonly prescribed to individuals with hypertension to help lower blood pressure by reducing blood volume and promoting sodium and water excretion.
Edema: benzthiazide can be used to manage edema associated with various conditions like heart failure, liver disease, and kidney disorders.
Heart Failure: benzthiazide’s diuretic effects can help reduce fluid buildup in individuals with congestive heart failure, which may improve symptoms and overall cardiac function.
Cirrhosis: benzthiazide may be considered in individuals with cirrhosis to manage ascites (accumulation of fluid in the abdominal cavity) and edema.
Nephrolithiasis: In some cases, benzthiazide can be used to prevent kidney stones formation by reducing the concentration of calcium in the urine.
Diabetes Mellitus: benzthiazide’s blood pressure-lowering effects can benefit individuals with diabetes, especially those who have co-existing hypertension.
Hypercalciuria: benzthiazide may be used to manage hypercalciuria (excessive calcium in the urine), which can contribute to the formation of kidney stones.
Osteoporosis: benzthiazide’s effects on calcium metabolism may be considered in individuals with osteoporosis, although other treatments are typically preferred for managing this condition.
Chronic Kidney Disease (CKD): benzthiazide may be used cautiously in individuals with CKD to manage fluid retention and blood pressure. Dose adjustments may be necessary based on renal function.
Hyponatremia: benzthiazide’s effects on fluid balance may be considered in individuals with hyponatremia (low blood sodium levels).
Pregnancy consideration: pregnancy category C
Lactation: excretion into human milk: unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology:
benzthiazide is a diuretic medication that exerts its pharmacological effects primarily by inhibiting sodium and chloride ions reabsorption in the renal tubules of the kidneys. This mechanism leads to increased excretion of sodium, chloride, and water in the urine, resulting in reduced blood volume and decreased fluid accumulation in the body’s tissues.
By promoting diuresis, benzthiazide helps lower blood pressure and edema. Additionally, its potassium-sparing properties help maintain a balance of electrolytes. benzthiazide’s actions contribute to its role in treating hypertension and conditions characterized by excessive fluid accumulation, making it a valuable component in the management of cardiovascular and renal disorders.
Pharmacodynamics:
Diuretic Effect: benzthiazide is a thiazide diuretic that acts primarily in the distal convoluted tubules of the kidneys. It inhibits the sodium-chloride symporter (NCC) in the tubular cells, reducing the reabsorption of sodium and chloride ions. This leads to increased excretion of sodium, chloride, and water in the urine.
Water Excretion: By promoting the excretion of sodium and chloride, benzthiazide indirectly increases water excretion. This results in diuresis, which reduces blood volume and subsequently lowers blood pressure.
Blood Pressure Reduction: The diuretic effect of benzthiazide decreases blood volume and cardiac preload, leading to a reduction in blood pressure. This makes benzthiazide effective in managing hypertension (high blood pressure).
Electrolyte Balance: While benzthiazide enhances the excretion of sodium and chloride, it also has potassium-sparing properties. It promotes the excretion of sodium while helping to retain potassium, which is important for maintaining proper electrolyte balance.
Calcium Metabolism: benzthiazide can affect calcium metabolism by increasing renal tubular calcium reabsorption. This can lead to decreased urinary calcium excretion and may have implications for conditions such as kidney stone prevention.
Antihypertensive Action: The reduction in blood volume and peripheral vascular resistance contributes to benzthiazide’s antihypertensive effects. By enhancing sodium and water excretion, it helps alleviate the excessive fluid load that can contribute to high blood pressure.
Pharmacokinetics:
Absorption
benzthiazide is administered orally in the form of tablets or capsules. It is well-absorbed from the gastrointestinal tract, with peak plasma concentrations reached within a few hours after oral administration.
Distribution
benzthiazide is distributed throughout the body, including the extracellular fluid compartments. It may cross the placental barrier and be found in breast milk. Plasma protein binding of benzthiazide is low.
Metabolism
benzthiazide undergoes minimal metabolism in the liver. It is excreted unchanged in urine. The lack of significant metabolic transformation contributes to its simple pharmacokinetic profile.
Elimination and excretion
benzthiazide is primarily eliminated unchanged in the urine, with renal excretion being the main route of elimination. The drug and its metabolites are filtered by the kidneys and excreted into the urine. A small portion of the dose may be excreted in the feces. The elimination half-life of benzthiazide is 3 to 5 hours.
Administration:
Dosage Form: benzthiazide is available in oral tablet or capsule forms. Your prescription will specify the dosage strength and form prescribed by your healthcare provider.
Dosage Schedule: Follow the dosing schedule provided by your healthcare provider. benzthiazide is usually taken once daily in the morning, although the exact frequency and timing may vary depending on your medical needs.
With or Without Food: benzthiazide can be taken with or without food. However, to maintain consistent blood levels, it is recommended to take it with the same type of meal each day.
Swallowing: If you are taking tablets or capsules, swallow them whole with a glass of water.
Dosage Adjustment: Your healthcare provider may adjust the dosage based on your response to treatment, any potential side effects, and your specific medical condition. It is important to keep your healthcare provider informed about any changes in your health.
Patient information leaflet
Generic Name: benzthiazide
Pronounced: (BENZ-THY-uh-zide)
Why do we use benzthiazide?
Hypertension (High Blood Pressure): One of the primary uses of benzthiazide is to treat hypertension. It helps to lower blood pressure by the excretion of sodium and water.
Edema (Fluid Retention): benzthiazide is used to manage edema associated with conditions such as heart failure, liver disease, kidney disorders, and certain types of kidney stones. Its diuretic effect helps reduce fluid buildup in the body’s tissues.
Nephrolithiasis Prevention: In some cases, benzthiazide may be prescribed to prevent the formation of certain types of kidney stones. By reducing the concentration of calcium in the urine, it can help prevent the crystallization and aggregation of stone-forming substances.
Adjunctive Treatment: benzthiazide may be used as an adjunct to other antihypertensive medications to enhance blood pressure control and reduce the dosage of individual drugs.
Calcium Excretion: benzthiazide’s effects on calcium metabolism may be considered in specific cases where managing urinary calcium excretion is necessary.
News
Rare Uterine Lipoma Diagnosed Post-Surgery: Case Report
Posted on
News
Robotic Breakthrough in Brain Surgery
Posted on
News
Bangladesh Achieves Remarkable Reduction in Lead in Turmeric
Posted on
News
Suppressing Negative Thoughts Can Improve Mental Health
starting dose: 25-100 mg orally given two times a day after the meals
Maintenance dose: 50-150 mg daily given orally in 2-3 divided doses. Maximum recommended dose is 200 mg daily orally in 2-4 divided doses
Dose Adjustments
Dosing modifications Renal impairment
CrCl less than 25 mL/min: usually not recommended.
CrCl 25 to 80 mL/min: starting dose: 25 mg orally given two times a day after the meals. Maintenance dose: 50-100 mg daily given orally in a single or in two divided doses. Liver impairment
Not known
It may diminish the therapeutic efficacy when combined with pegloticase
Actions and spectrum:
Actions of benzthiazide:
Diuretic Effect: benzthiazide primarily acts as a diuretic by inhibiting sodium and chloride ions reabsorption in the renal tubules of the kidneys. This leads to increased excretion of sodium, chloride, and water in the urine.
Volume Reduction: By promoting the elimination of sodium and water, benzthiazide helps reduce blood volume and, consequently, lowers blood pressure. This makes it a useful medication for managing hypertension (high blood pressure).
Potassium Excretion: While benzthiazide increases the excretion of sodium and water, it also leads to the loss of potassium in the urine. This can potentially lead to hypokalemia (low blood potassium levels), so monitoring of potassium levels is important during treatment.
Spectrum of benzthiazide:
benzthiazide’s effects are primarily related to its diuretic action and its ability to lower blood pressure. It is used to manage several conditions, including:
Hypertension: benzthiazide is often prescribed as an antihypertensive medication to help lower blood pressure. By reducing blood volume, it helps decrease the strain on the heart and blood vessels.
Edema: Due to its diuretic properties, benzthiazide can be used to manage edema (fluid retention) associated with conditions such as heart failure, kidney disorders, and certain liver diseases.
Nephrolithiasis Prevention: benzthiazide may be used to help prevent kidney stones formation by reducing the concentration of calcium in the urine.
Adjunctive Treatment: benzthiazide can be prescribed in combination with other antihypertensive medications to enhance blood pressure control and reduce the dosage of individual drugs.
Calcium Excretion: In addition to sodium and water, benzthiazide also promotes the excretion of calcium in the urine. This effect may be beneficial in certain cases of hypercalcemia.
Frequency not defined
Hyperuricemia
hypokalemia
Hyponatremia
hypophosphatemia
hyperglycemia
hyperuricemia
Metabolic alkalosis
Hypomagnesemia
Hypercalcemia
hypercholesterolemia
Orthostatic hypotension
Diarrhea
Nausea
vomiting
Dizziness
Paresthesia
Xanthopsia
Restlessness
headache
Black Box Warning:
There is no known black box warning specifically associated with benzthiazide.
Contraindication/Caution:
Contraindication:
Hypersensitivity: Individuals with a known hypersensitivity or allergy to benzthiazide or other thiazide diuretics should not use this medication.
Severe Renal Impairment: benzthiazide is primarily eliminated through the kidneys. Individuals with severe renal impairment or kidney failure may not be able to effectively eliminate the drug, leading to potential accumulation and adverse effects. The medication may be contraindicated in this population.
Anuria: Anuria refers to the absence of urine production. benzthiazide’s mechanism of action relies on the production of urine to eliminate excess fluid and electrolytes. In cases of anuria, the medication’s effectiveness may be limited, and its use is contraindicated.
Hepatic Encephalopathy: benzthiazide can alter fluid and electrolyte balance in the body, which could potentially worsen hepatic encephalopathy, a neurological condition that occurs in advanced liver disease. Therefore, its use may be contraindicated in individuals with this condition.
Hypokalemia: Severe hypokalemia (low blood potassium levels) may be exacerbated by benzthiazide, as it promotes potassium excretion in the urine. Use in individuals with severe hypokalemia could lead to further imbalances and is contraindicated.
Electrolyte Imbalance: Individuals with significant electrolyte imbalances, such as hyponatremia (low blood sodium levels) or hypomagnesemia (low blood magnesium levels), should use benzthiazide with caution, as the medication can affect electrolyte levels.
Caution:
Electrolyte Imbalances: benzthiazide’s diuretic effect can lead to electrolyte imbalances, including hypokalemia (low blood potassium levels), hyponatremia (low blood sodium levels), and hypomagnesemia (low blood magnesium levels). Healthcare providers should regularly monitor electrolyte levels and make necessary adjustments to prevent and manage imbalances.
Renal Impairment: benzthiazide is primarily eliminated through the kidneys. Individuals with mild to moderate renal impairment may require dose adjustments or closer monitoring, while those with severe impairment may be at risk of accumulation and should use the medication with caution.
Hepatic Impairment: benzthiazide’s effects on fluid and electrolyte balance can impact individuals with liver disease, potentially worsening hepatic encephalopathy or other complications. Close monitoring and cautious use are advised in this population.
Gout: benzthiazide can elevate uric acid levels in the blood, potentially triggering or exacerbating gout attacks. Individuals with a history of gout should be monitored closely and managed accordingly.
Lipid and Glucose Levels: benzthiazide’s use may impact lipid profiles and glucose tolerance. Monitoring lipid and glucose levels can help manage any potential adverse effects.
Calcium Metabolism: benzthiazide can affect calcium metabolism, leading to potential hypercalcemia (high blood calcium levels). Close monitoring is important in individuals with conditions that can be affected by calcium levels, such as hyperparathyroidism.
Pregnancy and Lactation: The use of benzthiazide during pregnancy and breastfeeding requires careful consideration, as its effects the developing fetus or nursing infant are not well-established.
Comorbidities:
Hypertension: benzthiazide is commonly prescribed to individuals with hypertension to help lower blood pressure by reducing blood volume and promoting sodium and water excretion.
Edema: benzthiazide can be used to manage edema associated with various conditions like heart failure, liver disease, and kidney disorders.
Heart Failure: benzthiazide’s diuretic effects can help reduce fluid buildup in individuals with congestive heart failure, which may improve symptoms and overall cardiac function.
Cirrhosis: benzthiazide may be considered in individuals with cirrhosis to manage ascites (accumulation of fluid in the abdominal cavity) and edema.
Nephrolithiasis: In some cases, benzthiazide can be used to prevent kidney stones formation by reducing the concentration of calcium in the urine.
Diabetes Mellitus: benzthiazide’s blood pressure-lowering effects can benefit individuals with diabetes, especially those who have co-existing hypertension.
Hypercalciuria: benzthiazide may be used to manage hypercalciuria (excessive calcium in the urine), which can contribute to the formation of kidney stones.
Osteoporosis: benzthiazide’s effects on calcium metabolism may be considered in individuals with osteoporosis, although other treatments are typically preferred for managing this condition.
Chronic Kidney Disease (CKD): benzthiazide may be used cautiously in individuals with CKD to manage fluid retention and blood pressure. Dose adjustments may be necessary based on renal function.
Hyponatremia: benzthiazide’s effects on fluid balance may be considered in individuals with hyponatremia (low blood sodium levels).
Pregnancy consideration: pregnancy category C
Lactation: excretion into human milk: unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology:
benzthiazide is a diuretic medication that exerts its pharmacological effects primarily by inhibiting sodium and chloride ions reabsorption in the renal tubules of the kidneys. This mechanism leads to increased excretion of sodium, chloride, and water in the urine, resulting in reduced blood volume and decreased fluid accumulation in the body’s tissues.
By promoting diuresis, benzthiazide helps lower blood pressure and edema. Additionally, its potassium-sparing properties help maintain a balance of electrolytes. benzthiazide’s actions contribute to its role in treating hypertension and conditions characterized by excessive fluid accumulation, making it a valuable component in the management of cardiovascular and renal disorders.
Pharmacodynamics:
Diuretic Effect: benzthiazide is a thiazide diuretic that acts primarily in the distal convoluted tubules of the kidneys. It inhibits the sodium-chloride symporter (NCC) in the tubular cells, reducing the reabsorption of sodium and chloride ions. This leads to increased excretion of sodium, chloride, and water in the urine.
Water Excretion: By promoting the excretion of sodium and chloride, benzthiazide indirectly increases water excretion. This results in diuresis, which reduces blood volume and subsequently lowers blood pressure.
Blood Pressure Reduction: The diuretic effect of benzthiazide decreases blood volume and cardiac preload, leading to a reduction in blood pressure. This makes benzthiazide effective in managing hypertension (high blood pressure).
Electrolyte Balance: While benzthiazide enhances the excretion of sodium and chloride, it also has potassium-sparing properties. It promotes the excretion of sodium while helping to retain potassium, which is important for maintaining proper electrolyte balance.
Calcium Metabolism: benzthiazide can affect calcium metabolism by increasing renal tubular calcium reabsorption. This can lead to decreased urinary calcium excretion and may have implications for conditions such as kidney stone prevention.
Antihypertensive Action: The reduction in blood volume and peripheral vascular resistance contributes to benzthiazide’s antihypertensive effects. By enhancing sodium and water excretion, it helps alleviate the excessive fluid load that can contribute to high blood pressure.
Pharmacokinetics:
Absorption
benzthiazide is administered orally in the form of tablets or capsules. It is well-absorbed from the gastrointestinal tract, with peak plasma concentrations reached within a few hours after oral administration.
Distribution
benzthiazide is distributed throughout the body, including the extracellular fluid compartments. It may cross the placental barrier and be found in breast milk. Plasma protein binding of benzthiazide is low.
Metabolism
benzthiazide undergoes minimal metabolism in the liver. It is excreted unchanged in urine. The lack of significant metabolic transformation contributes to its simple pharmacokinetic profile.
Elimination and excretion
benzthiazide is primarily eliminated unchanged in the urine, with renal excretion being the main route of elimination. The drug and its metabolites are filtered by the kidneys and excreted into the urine. A small portion of the dose may be excreted in the feces. The elimination half-life of benzthiazide is 3 to 5 hours.
Administration:
Dosage Form: benzthiazide is available in oral tablet or capsule forms. Your prescription will specify the dosage strength and form prescribed by your healthcare provider.
Dosage Schedule: Follow the dosing schedule provided by your healthcare provider. benzthiazide is usually taken once daily in the morning, although the exact frequency and timing may vary depending on your medical needs.
With or Without Food: benzthiazide can be taken with or without food. However, to maintain consistent blood levels, it is recommended to take it with the same type of meal each day.
Swallowing: If you are taking tablets or capsules, swallow them whole with a glass of water.
Dosage Adjustment: Your healthcare provider may adjust the dosage based on your response to treatment, any potential side effects, and your specific medical condition. It is important to keep your healthcare provider informed about any changes in your health.
Patient information leaflet
Generic Name: benzthiazide
Pronounced: (BENZ-THY-uh-zide)
Why do we use benzthiazide?
Hypertension (High Blood Pressure): One of the primary uses of benzthiazide is to treat hypertension. It helps to lower blood pressure by the excretion of sodium and water.
Edema (Fluid Retention): benzthiazide is used to manage edema associated with conditions such as heart failure, liver disease, kidney disorders, and certain types of kidney stones. Its diuretic effect helps reduce fluid buildup in the body’s tissues.
Nephrolithiasis Prevention: In some cases, benzthiazide may be prescribed to prevent the formation of certain types of kidney stones. By reducing the concentration of calcium in the urine, it can help prevent the crystallization and aggregation of stone-forming substances.
Adjunctive Treatment: benzthiazide may be used as an adjunct to other antihypertensive medications to enhance blood pressure control and reduce the dosage of individual drugs.
Calcium Excretion: benzthiazide’s effects on calcium metabolism may be considered in specific cases where managing urinary calcium excretion is necessary.
News
Rare Uterine Lipoma Diagnosed Post-Surgery: Case Report
Posted on
News
Robotic Breakthrough in Brain Surgery
Posted on
News
Bangladesh Achieves Remarkable Reduction in Lead in Turmeric
Posted on
News
Suppressing Negative Thoughts Can Improve Mental Health
Posted on
ADVERTISEMENT
medtigo
benzthiazide
Brand Name :
Exna
Synonyms :
benzthiazide
Class :
Diuretics, Thiazides
Action and Spectrum
Actions and spectrum:
Actions of benzthiazide:
Diuretic Effect: benzthiazide primarily acts as a diuretic by inhibiting sodium and chloride ions reabsorption in the renal tubules of the kidneys. This leads to increased excretion of sodium, chloride, and water in the urine.
Volume Reduction: By promoting the elimination of sodium and water, benzthiazide helps reduce blood volume and, consequently, lowers blood pressure. This makes it a useful medication for managing hypertension (high blood pressure).
Potassium Excretion: While benzthiazide increases the excretion of sodium and water, it also leads to the loss of potassium in the urine. This can potentially lead to hypokalemia (low blood potassium levels), so monitoring of potassium levels is important during treatment.
Spectrum of benzthiazide:
benzthiazide’s effects are primarily related to its diuretic action and its ability to lower blood pressure. It is used to manage several conditions, including:
Hypertension: benzthiazide is often prescribed as an antihypertensive medication to help lower blood pressure. By reducing blood volume, it helps decrease the strain on the heart and blood vessels.
Edema: Due to its diuretic properties, benzthiazide can be used to manage edema (fluid retention) associated with conditions such as heart failure, kidney disorders, and certain liver diseases.
Nephrolithiasis Prevention: benzthiazide may be used to help prevent kidney stones formation by reducing the concentration of calcium in the urine.
Adjunctive Treatment: benzthiazide can be prescribed in combination with other antihypertensive medications to enhance blood pressure control and reduce the dosage of individual drugs.
Calcium Excretion: In addition to sodium and water, benzthiazide also promotes the excretion of calcium in the urine. This effect may be beneficial in certain cases of hypercalcemia.
Dosing & Uses
Drug Interaction
Adverse Reaction
Frequency not defined
Hyperuricemia
hypokalemia
Hyponatremia
hypophosphatemia
hyperglycemia
hyperuricemia
Metabolic alkalosis
Hypomagnesemia
Hypercalcemia
hypercholesterolemia
Orthostatic hypotension
Diarrhea
Nausea
vomiting
Dizziness
Paresthesia
Xanthopsia
Restlessness
headache
Black Box Warning
Black Box Warning:
There is no known black box warning specifically associated with benzthiazide.
Contraindication / Caution
Contraindication/Caution:
Contraindication:
Hypersensitivity: Individuals with a known hypersensitivity or allergy to benzthiazide or other thiazide diuretics should not use this medication.
Severe Renal Impairment: benzthiazide is primarily eliminated through the kidneys. Individuals with severe renal impairment or kidney failure may not be able to effectively eliminate the drug, leading to potential accumulation and adverse effects. The medication may be contraindicated in this population.
Anuria: Anuria refers to the absence of urine production. benzthiazide’s mechanism of action relies on the production of urine to eliminate excess fluid and electrolytes. In cases of anuria, the medication’s effectiveness may be limited, and its use is contraindicated.
Hepatic Encephalopathy: benzthiazide can alter fluid and electrolyte balance in the body, which could potentially worsen hepatic encephalopathy, a neurological condition that occurs in advanced liver disease. Therefore, its use may be contraindicated in individuals with this condition.
Hypokalemia: Severe hypokalemia (low blood potassium levels) may be exacerbated by benzthiazide, as it promotes potassium excretion in the urine. Use in individuals with severe hypokalemia could lead to further imbalances and is contraindicated.
Electrolyte Imbalance: Individuals with significant electrolyte imbalances, such as hyponatremia (low blood sodium levels) or hypomagnesemia (low blood magnesium levels), should use benzthiazide with caution, as the medication can affect electrolyte levels.
Caution:
Electrolyte Imbalances: benzthiazide’s diuretic effect can lead to electrolyte imbalances, including hypokalemia (low blood potassium levels), hyponatremia (low blood sodium levels), and hypomagnesemia (low blood magnesium levels). Healthcare providers should regularly monitor electrolyte levels and make necessary adjustments to prevent and manage imbalances.
Renal Impairment: benzthiazide is primarily eliminated through the kidneys. Individuals with mild to moderate renal impairment may require dose adjustments or closer monitoring, while those with severe impairment may be at risk of accumulation and should use the medication with caution.
Hepatic Impairment: benzthiazide’s effects on fluid and electrolyte balance can impact individuals with liver disease, potentially worsening hepatic encephalopathy or other complications. Close monitoring and cautious use are advised in this population.
Gout: benzthiazide can elevate uric acid levels in the blood, potentially triggering or exacerbating gout attacks. Individuals with a history of gout should be monitored closely and managed accordingly.
Lipid and Glucose Levels: benzthiazide’s use may impact lipid profiles and glucose tolerance. Monitoring lipid and glucose levels can help manage any potential adverse effects.
Calcium Metabolism: benzthiazide can affect calcium metabolism, leading to potential hypercalcemia (high blood calcium levels). Close monitoring is important in individuals with conditions that can be affected by calcium levels, such as hyperparathyroidism.
Pregnancy and Lactation: The use of benzthiazide during pregnancy and breastfeeding requires careful consideration, as its effects the developing fetus or nursing infant are not well-established.
Comorbidities:
Hypertension: benzthiazide is commonly prescribed to individuals with hypertension to help lower blood pressure by reducing blood volume and promoting sodium and water excretion.
Edema: benzthiazide can be used to manage edema associated with various conditions like heart failure, liver disease, and kidney disorders.
Heart Failure: benzthiazide’s diuretic effects can help reduce fluid buildup in individuals with congestive heart failure, which may improve symptoms and overall cardiac function.
Cirrhosis: benzthiazide may be considered in individuals with cirrhosis to manage ascites (accumulation of fluid in the abdominal cavity) and edema.
Nephrolithiasis: In some cases, benzthiazide can be used to prevent kidney stones formation by reducing the concentration of calcium in the urine.
Diabetes Mellitus: benzthiazide’s blood pressure-lowering effects can benefit individuals with diabetes, especially those who have co-existing hypertension.
Hypercalciuria: benzthiazide may be used to manage hypercalciuria (excessive calcium in the urine), which can contribute to the formation of kidney stones.
Osteoporosis: benzthiazide’s effects on calcium metabolism may be considered in individuals with osteoporosis, although other treatments are typically preferred for managing this condition.
Chronic Kidney Disease (CKD): benzthiazide may be used cautiously in individuals with CKD to manage fluid retention and blood pressure. Dose adjustments may be necessary based on renal function.
Hyponatremia: benzthiazide’s effects on fluid balance may be considered in individuals with hyponatremia (low blood sodium levels).
Pregnancy / Lactation
Pregnancy consideration: pregnancy category C
Lactation: excretion into human milk: unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology
Pharmacology:
benzthiazide is a diuretic medication that exerts its pharmacological effects primarily by inhibiting sodium and chloride ions reabsorption in the renal tubules of the kidneys. This mechanism leads to increased excretion of sodium, chloride, and water in the urine, resulting in reduced blood volume and decreased fluid accumulation in the body’s tissues.
By promoting diuresis, benzthiazide helps lower blood pressure and edema. Additionally, its potassium-sparing properties help maintain a balance of electrolytes. benzthiazide’s actions contribute to its role in treating hypertension and conditions characterized by excessive fluid accumulation, making it a valuable component in the management of cardiovascular and renal disorders.
Pharmacodynamics:
Diuretic Effect: benzthiazide is a thiazide diuretic that acts primarily in the distal convoluted tubules of the kidneys. It inhibits the sodium-chloride symporter (NCC) in the tubular cells, reducing the reabsorption of sodium and chloride ions. This leads to increased excretion of sodium, chloride, and water in the urine.
Water Excretion: By promoting the excretion of sodium and chloride, benzthiazide indirectly increases water excretion. This results in diuresis, which reduces blood volume and subsequently lowers blood pressure.
Blood Pressure Reduction: The diuretic effect of benzthiazide decreases blood volume and cardiac preload, leading to a reduction in blood pressure. This makes benzthiazide effective in managing hypertension (high blood pressure).
Electrolyte Balance: While benzthiazide enhances the excretion of sodium and chloride, it also has potassium-sparing properties. It promotes the excretion of sodium while helping to retain potassium, which is important for maintaining proper electrolyte balance.
Calcium Metabolism: benzthiazide can affect calcium metabolism by increasing renal tubular calcium reabsorption. This can lead to decreased urinary calcium excretion and may have implications for conditions such as kidney stone prevention.
Antihypertensive Action: The reduction in blood volume and peripheral vascular resistance contributes to benzthiazide’s antihypertensive effects. By enhancing sodium and water excretion, it helps alleviate the excessive fluid load that can contribute to high blood pressure.
Pharmacokinetics:
Absorption
benzthiazide is administered orally in the form of tablets or capsules. It is well-absorbed from the gastrointestinal tract, with peak plasma concentrations reached within a few hours after oral administration.
Distribution
benzthiazide is distributed throughout the body, including the extracellular fluid compartments. It may cross the placental barrier and be found in breast milk. Plasma protein binding of benzthiazide is low.
Metabolism
benzthiazide undergoes minimal metabolism in the liver. It is excreted unchanged in urine. The lack of significant metabolic transformation contributes to its simple pharmacokinetic profile.
Elimination and excretion
benzthiazide is primarily eliminated unchanged in the urine, with renal excretion being the main route of elimination. The drug and its metabolites are filtered by the kidneys and excreted into the urine. A small portion of the dose may be excreted in the feces. The elimination half-life of benzthiazide is 3 to 5 hours.
Adminstartion
Administration:
Dosage Form: benzthiazide is available in oral tablet or capsule forms. Your prescription will specify the dosage strength and form prescribed by your healthcare provider.
Dosage Schedule: Follow the dosing schedule provided by your healthcare provider. benzthiazide is usually taken once daily in the morning, although the exact frequency and timing may vary depending on your medical needs.
With or Without Food: benzthiazide can be taken with or without food. However, to maintain consistent blood levels, it is recommended to take it with the same type of meal each day.
Swallowing: If you are taking tablets or capsules, swallow them whole with a glass of water.
Dosage Adjustment: Your healthcare provider may adjust the dosage based on your response to treatment, any potential side effects, and your specific medical condition. It is important to keep your healthcare provider informed about any changes in your health.
Patient Information Leaflet
Patient information leaflet
Generic Name: benzthiazide
Pronounced: (BENZ-THY-uh-zide)
Why do we use benzthiazide?
Hypertension (High Blood Pressure): One of the primary uses of benzthiazide is to treat hypertension. It helps to lower blood pressure by the excretion of sodium and water.
Edema (Fluid Retention): benzthiazide is used to manage edema associated with conditions such as heart failure, liver disease, kidney disorders, and certain types of kidney stones. Its diuretic effect helps reduce fluid buildup in the body’s tissues.
Nephrolithiasis Prevention: In some cases, benzthiazide may be prescribed to prevent the formation of certain types of kidney stones. By reducing the concentration of calcium in the urine, it can help prevent the crystallization and aggregation of stone-forming substances.
Adjunctive Treatment: benzthiazide may be used as an adjunct to other antihypertensive medications to enhance blood pressure control and reduce the dosage of individual drugs.
Calcium Excretion: benzthiazide’s effects on calcium metabolism may be considered in specific cases where managing urinary calcium excretion is necessary.
